Search Results - "Ho, Connie H. M."

Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC) by Yeung, Cynthia S. Y., Chiang, C. L., Wong, Natalie S. M., Ha, S. K., Tsang, K. S., Ho, Connie H. M., Wang, B., Lee, Venus W. Y., Chan, Mark K. H., Lee, Francis A. S.

“…This study aims at evaluating the symptom response, response duration, and toxicity of single dose palliative liver radiotherapy (RT) for symptomatic HCC…”
Get full text

Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis by Wong, Tiffany CL, Chiang, Chi-Leung, Lee, Ann-Shing, Lee, Victor HF, Yeung, Cynthia SY, Ho, Connie HM, Cheung, Tan-To, Ng, Kelvin KC, Chok, Siu-Ho, Chan, Albert CY, Dai, Wing-Chiu, Wong, Frank CS, Luk, Mai-Yee, Leung, To-Wai, Lo, Chung-Mau

“…This study compared outcomes of nonresectable hepatocellular carcinoma (HCC) who had transarterial chemoembolization (TACE) vs. stereotactic body radiation…”
Get full text

Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B–C hepatocellular carcinoma by Chiang, C. L., Chan, Mark K. H., Yeung, Cynthia S. Y., Ho, Connie H. M., Lee, Francis A. S., Lee, Venus W. Y., Wong, Frank C. S., Blanck, Oliver

“…Purpose We retrospectively evaluated the efficacy and safety of stereotactic body radiotherapy (SBRT) combined with trans-arterial chemoembolization (TACE) as…”
Get full text

Efficacy, toxicities, and prognostic factors of stereotactic body radiotherapy for unresectable liver metastases by Choi, C K K, Ho, C H M, Wong, M Y P, Leung, R W K, Wong, F C S, Tung, S Y, Lee, F A S

“…This study aims to determine the outcomes of stereotactic body radiotherapy (SBRT) for liver metastases in patients not eligible for surgery. This study…”
Get full text

Role of plasma circulating HER2/EFTUD2 ratio in predicting pathological complete response (pCR) after neoadjuvant dual anti-HER2 therapy in HER2-positive breast cancer (HER2+ BC) by Chan, Jeffrey CH, Cho, William CS, Chow, James CH, Bao, Kelvin K H, Leung, Alex KC, Szeto, Michelle OY, Ho, Connie HM, Yiu, Harry HY

“…e12592 Background: Achieving pCR following neoadjuvant chemo and anti-HER2 therapy is associated with a significantly better survival in HER2+ BC. There is…”
Get full text

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT) by Ho, Connie H M, Chiang, Chi-Leung, Lee, Francis A S, Choi, Horace C W, Chan, Jeffery C H, Yeung, Cynthia S Y, Huang, J J, Chan, Mark K H, Blanck, Oliver, Wong, Frank C S

“…This work evaluated the prognostic performance of Child-Pugh (CP), albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PALBI) scores in hepatocellular…”
Get full text